Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV vs IM Methylergonovine for Uterine Contraction in C-Sections
NCT03303235Phase 1Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Jul 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of methylergometrine in uterine atony and postpartum hemorrhage (PPH) (2 arms), sponsored by Johns Hopkins University. Primary endpoint: Time to achieve adequate uterine tone at 10 minutes. Planned start Jul 2020; status: withdrawn.
02
Drugs
methylergometrine
03
Conditions
uterine atonypostpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT03303235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03303235.